The SYNTHIA General Assembly will take place in Berlin, Germany on22 and 23 September 2026 and will bring together our official consortium partners for dedicated sessions to connect, collaborate and exchange insights in the project's developments and discuss planned activities.
This years edition is hosted by SYNTHIA Partners Fraunhofer and Gates Ventures
- More details to follow
SYNTHIA is a multidisciplinary collaboration of 39 consortium partners - SDG developers, FAIR data experts, clinical researchers, developers of therapies and data-based tools, legal experts, socio-economic analysts, regulatory, policy advocacy, and communication experts - that will provide a 360º vision on how to advance healthcare applications through Synthetic Data use. We are set to revolutionize the field of personalized medicine by harnessing the power of synthetic data (SD). SYNTHIA focusses on 6 impactful diseases: Lung cancer, Breast cancer, Multiple Myeloma, Diffuse large B-cell lymphoma, Alzheimers Disease, and Type 2 diabetes. SYNTHIA is funded by the Innovative Health Initiative (IHI). Read more >
